Sickle Cell Disease (SCD) is a complex genetic disorder that requires continuous monitoring and precise diagnostics to improve patient outcomes. With advancements in medical imaging, molecular diagnostics, and artificial intelligence, healthcare professionals now have powerful tools to detect, predict, and manage complications in SCD patients more effectively. This course explores the latest breakthroughs in precision diagnostics, imaging technologies, and lab-based monitoring that are transforming SCD management. Participants will gain insights into the routine testing for diagnosing and treating individuals with SCD. It also unveils the key tests required to measure iron overload in SCD patients receiving blood transfusions.

The course also provides in-depth discussions on the latest evidence for inflammation and coagulation markers in SCD. The role of biomarkers in assessing SCD in diagnosing, treating, and managing SCD, especially in cases of organ damage. By the end of the course, participants will be equipped with the expertise to apply modern diagnostic tools in clinical and research settings, ultimately improving the quality of care for SCD patients.